Haemonetics Corp (HAE) Projected Price to Earnings
Haemonetics Corporation confirms its stability through investments in smart plasma collection systems and digital platforms. The operational foundation is based on sterile consumables logistics and FDA patent protection. The company's forward P/E ratio history demonstrates market expectations, where the value 19.60 serves as a baseline indicator of the current business valuation relative to projected earnings.
Financial and market metric breakdowns for Haemonetics Company (HAE)
- current price and projected stock value:
- market capitalization details:
- issuer book value statistics:
- debt and solvency information:
Total Debt to Equity Ratio Haemonetics Corporation|HAE - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Haemonetics Corporation|HAE - Company Total Debt|Debts to Book Capitalization Haemonetics Corp|HAE - Long-Term Debt|Company Short-Term Debts Haemonetics|Quick Ratio haemonetics.com
- earnings and market ratios statistics:
HAE - Net Financial Result|Projected Future Earnings Haemonetics Corporation|HAE - Price to Earnings Ratio|Forward P/E Multiple Haemonetics Corp.|HAE - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Haemonetics Corp|HAE - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Haemonetics|HAE - Earnings per share for the trailing year|Quarterly EPS earnings growth haemonetics.com|HAE - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Haemonetics Corporation
Fundamental company analysis:Haemonetics
Portfolio managers value the stable cash flow of Haemonetics Corporation (HAE), driven by regular supplies of hematology consumables. By analyzing changes in the company's forward P/E ratio on the GURU.Markets platform, an investor can observe the market consensus on future earnings per share, which allows them to filter out the noise and identify actual overvaluation or business degradation while operational momentum remains high.
Competitors of Haemonetics Corporation (HAE)
Projected Price to Earnings DXCM (Dexcom)|Forward P/E Multiple Penumbra Inc (PEN)|Novanta Corp - Projected Price to Earnings|Market Cap to Future Earnings Ratio INSP (Inspire Medical Systems Inc)|PROCEPT BioRobotics - Forward P/E Multiple|Market Cap to Projected Earnings conmed.com CNMD|PLSE: Forward P/E Multiple|Projected Price to Earnings InMode Ltd|Projected Price to Earnings PMI|SRDX: Future Price to Earnings Multiple|Future Price to Earnings Senseonics (SENS)|Projected Price to Earnings neuropace.com NPCE|Forward P/E Multiple TCMD (Tactile Medical)|SANUWAVE Health (SNWV) - Projected Price to Earnings Ratio|Outset - Forward P/E Multiple|ELMD (Electromed, Inc.) - Price to Future Earnings Ratio|LNSR: Forward P/E Multiple|RCEL - Market Cap to Projected Earnings|PROF (Profound Medical Corp) - Forward P/E Multiple|Projected Price to Earnings Baird Medical Corp (BDMD)|Forward P/E Multiple EDAP|Forward P/E Multiple apyxmedical.com (APYX)|Future Price to Earnings IceCure Medical ICCM|Pulmonx Corp - Future Price to Earnings|TELA: Projected Price to Earnings|Future Price to Earnings Multiple CTSO (Cytosorbents)|SRTS: Forward P/E Multiple|Projected Price to Earnings Ratio Zynex Corp (ZYXI)|Future Price to Earnings electroCore Inc|RBOT - Forward Price to Earnings Multiple|Projected Price to Earnings IINN (Inspira Technologies Oxy)|Forward P/E Multiple SeaStar Medical Holding Corporation (ICU)|Forward P/E Multiple IRIX (IRIDEX)|Market Cap to Projected Earnings Intelligent Bio Solutions Inc (INBS)|XAIR - Future Price to Earnings|Price to Expected Earnings Ratio PFSA|strataskinsciences.com (SSKN) - Future Price to Earnings|Projected Price to Earnings glucotrack.com|NAOV (NanoVibronix) - Forward P/E Multiple|Projected Price to Earnings Ratio Venus Concept Corporation VERO|Future Price to Earnings Nuwellis, Inc. (NUWE)|aethlonmedical.com - Price to Future Earnings Ratio|Asensus Surgical - Projected Price to Earnings|Market Cap to Future Earnings Ratio AVGR (Avinger Inc.)|biosig.com - Forward P/E Multiple|Future Price to Earnings Multiple CUTR (Cutera Inc)|KNW: Forward P/E Multiple|inarimedical.com (NARI) - Forward P/E Multiple|NVRO (Nevro) - Forward P/E Multiple|Projected Price to Earnings Ratio ReShape Lifesciences Inc RSLS|Future Price to Earnings Silk Road Medical Inc. (SILK)
